CD1d-dependent endogenous and exogenous lipid antigen presentation

Current Opinion in Immunology

Volumn 34, Issue , 2015, Pages 116-125

  McEwen Smith, Rosanna M ^a   Salio, Mariolina ^a   Cerundolo, Vincenzo ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA GALACTURONOSYLCERAMIDE; CD1D ANTIGEN; GALACTOSYLDIACYLGLYCEROL; GLYCOLIPID; LIPID; MANNOSIDE; PHOSPHATIDYLINOSITOL MANNOSIDE; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ASPERGILLUS FUMIGATUS; AUTOPHAGY; B LYMPHOCYTE; BACTERIAL INFECTION; BACTEROIDES FRAGILIS; CELL ACTIVATION; CELL MATURATION; COMMENSAL; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INVARIANT NATURAL KILLER T CELL; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NATURAL KILLER T CELL; NONHUMAN; REVIEW; SPHINGOMONAS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; CYTOLOGY; IMMUNOLOGY; INTESTINE FLORA; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1D; AUTOPHAGY; B-LYMPHOCYTES; DENDRITIC CELLS; GASTROINTESTINAL MICROBIOME; HUMANS; LIPIDS; NATURAL KILLER T-CELLS;

EID: 84925218234     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.03.004     Document Type: Review

References (79)

1. Godfrey D.I., MacDonald H.R., Kronenberg M., Smyth M.J., Van Kaer L. NKT cells: what's in a name. Nat Rev Immunol 2004, 4:231-237.
2. Bendelac A., Savage P., Teyton L. The biology of NKT cells. Annu Rev Immunol 2007, 25:297-336.
3. + T cells in major histocompatibility complex class II-deficient mice. J Exp Med 1995, 182:993-1004.
4. Behar S.M., Podrebarac T.A., Roy C.J., Wang C.R., Brenner M.B. Diverse TCRs recognize murine CD1. J Immunol 1999, 162:161-167.
5. Chiu Y.H., Jayawardena J., Weiss A., Lee D., Park S.H. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 1999, 189:103-110.
6. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
7. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., Zajonc D.M., Ben-Menachem G., Ainge G.D., Painter G.F., et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006, 7:978-986.
8. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., Tsuji M., Kawahara K., Wong C.H., Kronenberg M.1. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005, 434:520-525.
9. Mattner J., DeBord K.L., Ismail N., Goff R.D., Cantu C., Zhou D., Saint-Mezard P., Wang V., Gao Y., Yin N., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529.
10. Zajonc D.M., Cantu C., Mattner J., Zhou D., Savage P.B., Bendelac A., Wilson I.A., Teyton L. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol 2005, 6:810-818.
11. Zhou D.P., Mattner J., Cantu C., Schrantz N., Yin N., Gao Y., Sagiv Y., Hudspeth K., Wu Y.P., Yamashita T., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306:1786-1789.
12. Silk J.D., Salio M., Reddy B.G., Shepherd D., Gileadi U., Brown J., Masri S.H., Polzella P., Ritter G., Besra G.S., et al. Cutting edge: nonglycosidic CD1d lipid ligands activate human and murine invariant NKT cells. J Immunol 2008, 180:6452-6456.
13. Cox D., Fox L., Tian R., Bardet W., Skaley M., Mojsilovic D., Gumperz J., Hildebrand W. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 2009, 4:e5325.
14. Fox L.M., Cox D.G., Lockridge J.L., Wang X., Chen X., Scharf L., Trott D.L., Ndonye R.M., Veerapen N., Besra G.S., et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 2009, 7:e1000228.
15. Brigl M., Bry L., Kent S.C., Gumperz J.E., Brenner M.B. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003, 4:1230-1237.
16. Brennan P.J., Tatituri R.V.V., Heiss C., Watts G.F.M., Hsu F.-F., Veerapen N., Cox L.R., Azadi P., Besra G.S., Brenner M.B. Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction. Proc Natl Acad Sci USA 2014, 111:13433-13438.
17. Salio M., Speak A.O., Shepherd D., Polzella P., Illarionov P.A., Veerapen N., Besra G.S., Platt F.M., Cerundolo V. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci USA 2007, 104:20490-20495.
18. Paget C., Mallevaey T., Speak A.O., Torres D., Fontaine J., Sheehan K.C., Capron M., Ryffel B., Faveeuw C., Leite de Moraes M., et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 2007, 27:597-609.
19. Pei B., Speak A.O., Shepherd D., Butters T., Cerundolo V., Platt F.M., Kronenberg M. Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids. J Immunol 2011, 186:1348-1360.
20. Brennan P.J., Tatituri R.V.V., Brigl M., Kim E.Y., Tuli A., Sanderson J.P., Gadola S.D., Hsu F.-F., Besra G.S., Brenner M.B. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011, 12:1202-1211.
21. Kitamura H., Iwakabe K., Yahata T., Nishimura S., Ohta A. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999, 189:1121-1128.
22. Kain L., Webb B., Brian L., Anderson S., Deng M., Holt A., Costanzo M., Zhao K., Self A., Teyton C., Everett, et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian α-linked glycosylceramides. Immunity 2014, 41:543-554.
23. Gapin L., Godfrey D.I., Rossjohn J. Natural killer T cell obsession with self-antigens. Curr Opin Immunol 2013, 25:168-173.
24. Patel O., Pellicci D.G., Gras S., Sandoval-Romero M.L., Uldrich A.P., Mallevaey T., Clarke A.J., Le Nours J., Theodossis A., Cardell S.L., et al. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. Nat Immunol 2012, 13:857-863.
25. Chang D.H., Deng H., Matthews P., Krasovsky J., Ragupathi G., Spisek R., Mazumder A., Vesole D.H., Jagannath S., Dhodapkar M.V. Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood 2008, 112:1308-1316.
26. Zeissig S., Murata K., Sweet L., Publicover J., Hu Z., Kaser A., Bosse E., Iqbal J., Hussain M.M., Balschun K., et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med 2012, 18:1060-1068.
27. Nair S., Boddupalli C.S., Verma R., Liu J., Yang R., Pastores G.M., Mistry P.K., Dhodapkar M.V. Type II NKT-TFH cells against Gaucher lipids regulate B cell immunity and inflammation. Blood 2014, 125:1256-1271.
28. Rhost S., Lofbom L., Rynmark B.M., Pei B., Mansson J.E., Teneberg S., Blomqvist M., Cardell S.L. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte. Eur J Immunol 2012, 42:2851-2860.
29. Zhao J., Weng X., Bagchi S., Wang C.R. Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response. Proc Natl Acad Sci USA 2014, 111:2674-2679.
30. Borg N.A., Wun K.S., Kjer-Nielsen L., Wilce M.C.J., Pellicci D.G., Koh R., Besra G.S., Bharadwaj M., Godfrey D.I., McCluskey J., et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007, 448:44-49.
31. Wu D., Xing G.W., Poles M.A., Horowitz A., Kinjo Y. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci USA 2005, 102:1351-1356.
32. McCarthy C., Shepherd D., Fleire S., Stronge V.S., Koch M., Illarionov P.A., Bossi G., Salio M., Denkberg G., Reddington F., et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 2007, 204:1131-1144.
33. Wun K.S., Borg N.A., Kjer-Nielsen L., Beddoe T., Koh R., Richardson S.K., Thakur M., Howell A.R., Scott-Browne J.P., Gapin L., et al. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR. J Exp Med 2008, 205:939-949.
34. Wun K.S., Cameron G., Patel O., Pang S.S., Pellicci D.G., Sullivan L.C., Keshipeddy S., Young M.H., Uldrich A.P., Thakur M.S., et al. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 2011, 34:327-339.
35. Mallevaey T., Clarke A.J., Scott-Browne J.P., Young M.H., Roisman L.C., Pellicci D.G., Patel O., Vivian J.P., Matsuda J.L., McCluskey J., et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 2011, 34:315-326.
36. Bourgeois E.A., Subramaniam S., Cheng T.Y., De Jong A., Layre E., Ly D., Salimi M., Legaspi A., Modlin R.L., Salio M., et al. Bee venom processes human skin lipids for presentation by CD1a. J Exp Med 2015, 212:149-163.
37. Sriram V., Du W., Gervay-Hague J., Brutkiewicz R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 2005, 35:1692-1701.
38. Fischer K., Scotet E., Niemeyer M., Koebernick H., Zerrahn J. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA 2004, 101:10685-10690.
39. Chang Y.J., Kim H.Y., Albacker L.A., Lee H.H., Baumgarth N., Akira S., Savage P.B., Endo S., Yamamura T., Maaskant J., et al. Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity. J Clin Invest 2011, 121:57-69.
40. Albacker L.A., Chaudhary V., Chang Y.J., Kim H.Y., Chuang Y.T., Pichavant M., DeKruyff R.H., Savage P.B., Umetsu D.T. Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity. Nat Med 2013, 19:1297-1304.
41. Wingender G., Rogers P., Batzer G., Lee M.S., Bai D., Pei B., Khurana A., Kronenberg M., Horner A.A. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J Exp Med 2011, 208:1151-1162.
42. An D., Oh S.F., Olszak T., Neves J.F., Avci F.Y., Erturk-Hasdemir D., Lu X., Zeissig S., Blumberg R.S., Kasper D.L. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 2014, 156:123-133.
43. Wieland Brown L.C., Penaranda C., Kashyap P.C., Williams B.B., Clardy J., Kronenberg M., Sonnenburg J.L., Comstock L.E., Bluestone J.A., Fischbach M.A. Production of α-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol 2013, 11:e1001610.
44. + T cells shape the formation of invariant NKT cells. J Immunol 2010, 184:1218-1226.
45. Wingender G., Stepniak D., Krebs P., Lin L., McBride S., Wei B., Braun J., Mazmanian S.K., Kronenberg M. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 2012, 143:418-428.
46. Silk J.D., Hermans I.F., Gileadi U., Chong T.W., Shepherd D., Salio M., Mathew B., Schmidt R.R., Lunt S.J., Williams K.J., et al. Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 2004, 114:1800-1811.
47. Courtney A.N., Nehete P.N., Nehete B.P., Thapa P., Zhou D., Sastry K.J. Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens. Vaccine 2009, 27:3335-3341.
48. Olszak T., An D., Zeissig S., Vera M.P., Richter J., Franke A., Glickman J.N., Siebert R., Baron R.M., Kasper D.L., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.
49. Bendelac A., Bonneville M., Kearney J.F. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001, 1:177-186.
50. Stanic A.K., De Silva A.D., Park J.J., Sriram V., Ichikawa S. Defective presentation of the CD1d1-restricted natural Vα14Jα18 NKT lymphocyte antigen caused by beta-d-glucosylceramide synthase deficiency. Proc Natl Acad Sci USA 2003, 100:1849-1854.
51. Darmoise A., Teneberg S., Bouzonville L., Brady R.O., Beck M., Kaufmann S.H.E., Winau F. Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells. Immunity 2010, 33:216-228.
52. Porubsky S., Speak A.O., Luckow B., Cerundolo V., Platt F.M., Groene H.-J. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci USA 2007, 104:5977-5982.
53. Porubsky S., Speak A.O., Salio M., Jennemann R., Bonrouhi M., Zafarulla R., Singh Y., Dyson J., Luckow B., Lehuen A., et al. Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells. J Immunol 2012, 189:3007-3017.
54. Gadola S.D., Silk J.D., Jeans A., Illarionov P.A., Salio M. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. J Exp Med 2006, 203:2293-2303.
55. Sagiv Y., Hudspeth K., Mattner J., Schrantz N., Stern R.K. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J Immunol 2006, 177:26-30.
56. Schumann J., Facciotti F., Panza L., Michieletti M., Compostella F., Collmann A., Mori L., De Libero G.1. Differential alteration of lipid antigen presentation to NKT cells due to imbalances in lipid metabolism. Eur J Immunol 2007, 37:1431-1441.
57. Facciotti F., Ramanjaneyulu G.S., Lepore M., Sansano S., Cavallari M., Kistowska M., Forss-Petter S., Ni G., Colone A., Singhal A., et al. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat Immunol 2012, 13:474-480.
58. Prigozy T.I., Naidenko O., Qasba P., Elewaut D., Brossay L., Khurana A., Natori T., Koezuka Y., Kulkarni A., Kronenberg M. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001, 291:664-667.
59. Holzapfel K.L., Tyznik A.J., Kronenberg M., Hogquist K.A. Antigen-dependent versus-independent activation of invariant NKT cells during infection. J Immunol 2014, 192:5490-5498.
60. Huang J., Brameshuber M., Zeng X., Xie J., Li Q.J., Chien Y.H., Valitutti S., Davis M.M. A single peptide-major histocompatibility complex ligand triggers digital cytokine secretion in CD4(+) T cells. Immunity 2013, 39:846-857.
61. Irvine D.J., Purbhoo M.A., Krogsgaard M., Davis M.M. Direct observation of ligand recognition by T cells. Nature 2002, 419:845-849.
62. Purbhoo M.A., Irvine D.J., Huppa J.B., Davis M.M. T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004, 5:524-530.
63. Moran A.E., Holzapfel K.L., Xing Y., Cunningham N.R., Maltzman J.S., Punt J., Hogquist K.A. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med 2011, 208:1279-1289.
64. Rossjohn J., Pellicci D.G., Patel O., Gapin L., Godfrey D.I. Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 2012, 12:845-857.
65. Pellicci D.G., Clarke A.J., Patel O., Mallevaey T., Beddoe T., Le Nours J., Uldrich A.P., McCluskey J., Besra G.S., Porcelli S.A., et al. Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors. Nat Immunol 2011, 12:827-833.
66. Yu E.D., Girardi E., Wang J., Zajonc D.M. Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells. J Immunol 2011, 187:2079-2083.
67. Pei B., Vela J.L., Zajonc D., Kronenberg M. Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells. Ann N Y Acad Sci 2012, 1253:68-79.
68. Wun K.S., Ross F., Patel O., Besra G.S., Porcelli S.A., Richardson S.K., Keshipeddy S., Howell A.R., Godfrey D.I., Rossjohn J. Human and mouse type I natural killer T cell antigen receptors exhibit different fine specificities for CD1d-antigen complex. J Biol Chem 2012, 287:39139-39148.
69. Chen X., Wang X., Keaton J.M., Reddington F., Illarionov P.A., Besra G.S., Gumperz J.E. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J Immunol 2007, 178:6181-6190.
70. Paduraru C., Bezbradica J.S., Kunte A., Kelly R., Shayman J.A., Veerapen N., Cox L.R., Besra G.S., Cresswell P. Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition. Proc Natl Acad Sci USA 2013, 110:5097-5102.
71. Kang S.J., Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 2004, 5:175-181.
72. Zhou D., Cantu C., Sagiv Y., Schrantz N., Kulkarni A.B. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 2004, 303:523-527.
73. Salio M., Ghadbane H., Dushek O., Shepherd D., Cypen J., Gileadi U., Aichinger M.C., Napolitani G., Qi X., van der Merwe P.A., et al. Saposins modulate human invariant Natural Killer T cells self-reactivity and facilitate lipid exchange with CD1d molecules during antigen presentation. Proc Natl Acad Sci USA 2013, 110:E4753-E4761.
74. Salio M., Puleston D.J., Mathan T.S.M., Shepherd D., Stranks A.J., Adamopoulou E., Veerapen N., Besra G.S., Hollander G.A., Simon A.K., et al. Essential role for autophagy during invariant NKT cell development. Proc Natl Acad Sci USA 2014, 111:E5678-E5687.
75. Deretic V., Saitoh T., Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013, 13:722-737.
76. Settembre C., Ballabio A. Lysosome: regulator of lipid degradation pathways. Trends in Cell Biology 2014, 24:743-750.
77. Parekh V.V., Wu L., Boyd K.L., Williams J.A., Gaddy J.A., Olivares-Villagomez D., Cover T.L., Zong W.X., Zhang J., Van Kaer L. Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific deletion of Vps34. J Immunol 2013, 190:5086-5101.
78. + T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat Immunol 2011, 12:616-623.
79. Lynch L., Michelet X., Zhang S., Brennan P.J., Moseman A., Lester C., Besra G., Vomhof-Dekrey E.E., Tighe M., Koay H.-F., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue. Nat Immunol 2015, 16:85-95.